ReShape Lifesciences: Clinical Trials

11 trials sponsored by ReShape Lifesciences, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 4 completed, 1 withdrawn. 8 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 4, Unknown 3, Withdrawn 1
Phase 21Unknown 1
Phase 31Unknown 1

Follow ReShape Lifesciences: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intragastric Balloon With Lifestyle Intervention vs. Lifestyle Intervention in Obese Patients With NASH
Intragastric balloon, Lifestyle intervention - Obesity, NASH - Nonalcoholic Steatohepatitis
Not applicableWithdrawnJohns Hopkins University2021-03-012021-03-30
ReShape Vest™ for the Treatment of Obesity (Europe)
Laparoscopic Gastric Vest (LGV) - Obesity, Weight Loss
Phase 2 / Phase 3UnknownReShape Lifesciences652019-03-252020-02-24
vBloc Now - Registry
vBloc Maestro Rechargeable System - Obesity, Morbid
UnknownReShape Lifesciences1252017-12-272018-07-26
The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol
vBloc Maestro Rechargeable System, vBloc Achieve Weight Management Program, Control Weight Management (CWM) program - Obesity, Morbid
Not applicableUnknownReShape Lifesciences42017-08-302019-05-22
A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
Reshape Integrated Dual Balloon - Obesity
UnknownReShape Lifesciences1862016-09-012019-03-29
A Prospective, Randomized Multicenter Study to Evaluate the Safety and Efficacy of the ReShape Duo™ Intragastric Balloon System in Obese Subjects
ReShape Duo balloon, Diet counseling, Exercise counseling - Obesity
Not applicableCompletedReShape Lifesciences3262012-08-012015-12-07
The Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity
vBloc (Active Device), Sham (Non-active Device) - Obesity
Not applicableUnknownReShape Lifesciences2392011-05-012017-08-30
The Safety and Efficacy of the ReShape Intragastric Balloon in Obese Subjects
ReShape Intragastric Balloon, Control Arm - Obesity
Not applicableCompletedReShape Lifesciences302010-02-012016-05-13
ReShape Intragastric Balloon for the Treatment of Obesity
ReShape Duo Balloon - Obesity
Not applicableCompletedReShape Lifesciences262009-09-012015-09-29
EMPOWER Clinical Trial: Vagal Blocking for Obesity Control
Therapy ON, Therapy OFF - Obesity
Not applicableCompletedReShape Lifesciences2942007-08-012018-08-24
Vagal Blocking for Obesity Control
Active, implantable, intra-abdominal vagal blocking medical device - Obesity
Not applicableUnknownReShape Lifesciences1202005-11-012012-02-02

Conditions studied

Obesity (10)  ·  Obesity, Morbid (3)  ·  Weight Loss (3)  ·  Non-alcoholic Fatty Liver Disease (1)

Countries

United States (6)  ·  Australia (3)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Charles J Billington, MD (2)  ·  Mary Lou Mooney (2)  ·  Charles Billington, M.D. (1)  ·  Dov Gal (1)  ·  Jaime Ponce, MD (1)  ·  John Lehmann, MD, MPH (1)  ·  Michael Sarr, M.D. (1)  ·  Michael Sarr, MD (1)  ·  Scott Shikora (1)  ·  Vivek Kumbhari, MD (1)

Results publications

PMID 23984050, PMID 25182100, PMID 27506803